Chemfab Alkalis Appoints MSKC & Associates LLP as Statutory Auditors for Five Years
Chemfab Alkalis Limited shareholders approved the appointment of MSKC & Associates LLP as Statutory Auditors for a five-year term. The appointment, effective from the conclusion of the 17th AGM until the 22nd AGM, follows the tenure expiry of the previous auditor, Deloitte Haskins & Sells LLP.
The appointment of statutory auditors is a routine compliance requirement for listed companies and typically does not have a direct, immediate impact on the company's operations or financial performance.
The announcement is a routine corporate action regarding the appointment of statutory auditors, which is a standard procedure. It does not inherently suggest positive or negative performance or outlook for the company.
Chemfab Alkalis Limited announced the appointment of M/s. MSKC & Associates LLP as the Statutory Auditors of the Company. This appointment was approved by the shareholders at the Annual General Meeting (AGM) held on September 9, 2026.
The shareholders considered and approved the appointment of M/s. MSKC & Associates LLP (FRN. 001595S/S000168) for a first term of five consecutive years. This term will commence from the conclusion of the 17th AGM until the conclusion of the 22nd AGM of the Company.
This follows a previous intimation filed on July 29, 2026, regarding the initial appointment of M/s. MSK C & Associates LLP. The change in auditors is consequent upon the expiry of the tenure of the existing Statutory Auditor, Deloitte Haskins & Sells LLP. MSKC & Associates LLP is an Indian LLP registered with the Institute of Chartered Accountants of India and the PCAOB, offering services in Audit Assurance, Tax, and Advisory.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under auditor changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.